Evidence map›Paper›PMID 41883528›Full record

ArticleDigital health

Improving stain normalization for digital histological image analysis based on the cycle generative adversarial network identity loss model.

Jung-Ting Chen, Yen-Yin Lin, Tun-Wen Pai

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jung-Ting ChenDepartment of Computer Science and Information Engineering, National Taipei University of Technology, Taipei, Taiwan.
Yen-Yin LinJelloX Biotech Inc., Hsinchu, Taiwan.
Tun-Wen PaiDepartment of Computer Science and Information Engineering, National Taipei University of Technology, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-2869-4169

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Stain color variations caused by differences in staining environments and scanning devices pose a major challenge for deep learning-based analysis of digital histopathological images. This study aims to develop a robust stain normalization framework that preserves structural information while enabling stable color-domain conversion across heterogeneous stain domains. Methods: We propose a generative adversarial network (GAN)-based training and testing framework, termed I-GAN, which integrates StainGAN and Stain-to-Stain Translation (STST). The method incorporates identity loss within an RGB-grayscale training strategy and applies RGB images during testing to preserve original stain information. Performance was evaluated on the MITOS-ATYPIA 14 dataset using SSIM, PSNR, and DeltaE-ITP, and further assessed on downstream classification tasks using Camelyon17 and the ICIAR2018 BACH Challenge datasets. Results: On MITOS-ATYPIA 14, I-GAN achieved an SSIM of 0.980, a PSNR of 29.579, and a DeltaE-ITP of 46.284, indicating superior structural preservation and color fidelity. For classification tasks, I-GAN obtained an average precision of 0.964 on Camelyon17 and an accuracy of 0.87, precision of 0.86, and recall of 0.87 on the ICIAR2018 BACH dataset. Conclusions: The proposed I-GAN framework improves stain normalization for hematoxylin and eosin-stained digital histopathology images by preserving structural integrity and achieving accurate color-domain conversion. These results demonstrate the robustness and practical applicability of the proposed approach for medical image analysis.

Indexed as

color transformationdeep learningmedical image recognitionstain normalization

Identifiers

PMID41883528
PMCPMC13009868

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.